Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Kumar

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Letters in Applied Microbiology|January 17, 2009
Disruption of fungal and bacterial biofilms by lauroyl glucoseD H Dusane, J K Rajput, A R Kumar, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 1, 2021
Antibody-drug conjugate as targeted therapeutics against hepatocellular carcinoma: preclinical studies and clinical relevanceM Murali, A R Kumar, B Nair, et al.
Cancer|May 1, 1975
Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumorsP H Gutin, C B Wilson, A R Kumar, et al.
Leukemia|August 18, 2017
Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretionB Kumar, M Garcia, L Weng, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Letters in Applied Microbiology|January 17, 2009
Disruption of fungal and bacterial biofilms by lauroyl glucoseD H Dusane, J K Rajput, A R Kumar, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 1, 2021
Antibody-drug conjugate as targeted therapeutics against hepatocellular carcinoma: preclinical studies and clinical relevanceM Murali, A R Kumar, B Nair, et al.
Cancer|May 1, 1975
Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumorsP H Gutin, C B Wilson, A R Kumar, et al.
Leukemia|August 18, 2017
Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretionB Kumar, M Garcia, L Weng, et al.
Pageof 5